Joana Marto

Dr. Joana Marto

Department of Pharmaceutics, Universidade de Lisboa and Research Institute for Medicine (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa – Portugal
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Cleaner Production
Verified
Journal Article
Closed access
SBSara Bom
Sara Bom
JJJ. Jorge
J. Jorge
Helena M RibeiroHelena M Ribeiro
Helena M Ribeiro
Joana MartoJoana Marto
Joana Marto

1 December 2017 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MSMariana Silva
Mariana Silva
RCRaquel Calado
Raquel Calado
Joana MartoJoana Marto
Joana Marto
Ana BettencourtAna Bettencourt
Ana Bettencourt
AAAntonio Almeida
Antonio Almeida
Luís Miguel GoncalvesLuís Miguel Goncalves
Luís Miguel Goncalves
Pharmaceutical approaches based on nanotechnologies and the development of eye drops composed of the mucoadhesive polymers chitosan and hyaluronic acid are emerging strategies for the efficient treatment of ocular diseases. These innovative nanoparticulate systems aim to increase drugs’ bioavailability at the ocular surface. For the successful development of these systems, the evaluation of mucoahesiveness (the interaction between the ocular delivery system and mucins present on the eye) is of utmost importance. In this context, the aim of the present work was to investigate the mucoadhesivity of a novel nanoparticle eye drop formulation containing an antibiotic (ceftazidime) intended to treat eye infections. Eye drop formulations comprised a polymer (hydroxypropyl) methyl cellulose (HPMC) 0.75% (w/v) in an isotonic solution incorporating chitosan/sodium tripolyphosphate (TPP)-hyaluronic acid-based nanoparticles containing ceftazidime. The viscosity of the nanoparticles, and the gels incorporating the nanoparticles were characterized in contact with mucin at different mass ratios, allowing the calculation of the rheological synergism parameter (∆η). Results showed that at different nanoparticle eye formulation:mucin weight ratios, a minimum in viscosity occurred which resulted in a negative rheological synergism. Additionally, the results highlighted the mucoadhesivity of the novel ocular formulation and its ability to interact with the ocular surface, thus increasing the drug residence time in the eye. Moreover, the in vitro release and permeation studies showed a prolonged drug release profile from the chitosan/TPP-hyaluronic acid nanoparticles gel formulation. Furthermore, the gel formulations were not cytotoxic on ARPE-19 and HEK293T cell lines, evaluated by the metabolic and membrane integrity tests. The formulation was stable and the drug active, as shown by microbiological studies. In conclusion, chitosan/TPP-hyaluronic acid nanoparticle eye drop formulations are a promising platform for ocular drug delivery with enhanced mucoadhesive properties.

24 January 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
SBSara Bom
Sara Bom
RRRicardo Ribeiro
Ricardo Ribeiro
Helena M RibeiroHelena M Ribeiro
Helena M Ribeiro
Catarina Ferreira SantosCatarina Ferreira Santos
Catarina Ferreira Santos
Joana MartoJoana Marto
Joana Marto
One of the exciting future directions in the 3D printing field is the development of innovative personalized smart constructions for bio-applications, including drug delivery, namely high-throughput drug screening and customized topical/oral administration of pharmaceuticals, as well as tissue engineering. In this context, hydrogels have emerged as a promising material that, when combined with extrusion 3D printing, allow the creation of soft-material structures with defined spatial locations, that can be printed at room temperature and customized by tuning the geometric design and/or the formulation components. Thus, the efficacy and quality of such vehicles is dependent on formulation, design, and printing process parameters. However, hydrogel inks are often designed and characterized using different methods and this lack of uniformity impairs. Characterization techniques are usually arbitrary and differ among research groups, challenging the inference of possible conclusions on hydrogel behaviour and potential applications. Therefore, to properly analyse the potential of a particular hydrogel ink formulation, we review, for the first time, the most frequently employed characterization procedures, from rheological approaches to printing parameters and settings, and discuss their relevance, limitations and drawbacks, and highlight future perspectives. Overall, to accelerate the development of high-quality 3D constructs, comprehensive characterization protocols for both pre-printing and printing assays should be adopted. Furthermore, their transversal adoption could serve as a boost in terms of quality requirements and regulatory aspects.

6 July 2023 in Sustainable Chemistry and Pharmacy
Verified
Journal Article
Open access
AMAna M. Martins
Ana M. Martins
Joana MartoJoana Marto
Joana Marto

1 January 2020 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
CFCatarina Faria-Silva
Catarina Faria-Silva
AAAndreia Ascenso
Andreia Ascenso
ACAna Costa
Ana Costa
Joana MartoJoana Marto
Joana Marto
MCManuela Carvalheiro
Manuela Carvalheiro
Sandra SimõesSandra Simões
Sandra Simões

30 June 2022 in Cosmetics
Verified
Journal Article
Open access
PDF file
MFMariana Ferreira
Mariana Ferreira
Ana MatosAna Matos
Ana Matos
ACAna Couras
Ana Couras
Joana MartoJoana Marto
Joana Marto
Helena M RibeiroHelena M Ribeiro
Helena M Ribeiro
To ensure safety and efficacy, cosmetic products are regulated and controlled worldwide. However, the regulatory approaches of each country may be significantly different and impact the competitiveness and economic viability of the industry. This work presents an updated review and comparison of regulatory requirements from the European Union, United States of America, Canada, Japan, People’s Republic of China and Brazil. It outlines contents such as the definition, classification and categorization of cosmetics, pre-market requirements, ingredients management, general labelling requirements, regulation of claims concerning advertisement and commercial practices, increase of animal testing and marketing bans on cosmetic products. Furthermore, it weighs the impact of regulatory differences on the safety and accessibility of these products in the mentioned regions.